BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3469154)

  • 1. Comparison of the in vitro activity of ofloxacin and gentamicin against isolates from hospitalised patients.
    Adeyemi-Doro FA; Rotowa NA
    Infection; 1986; 14 Suppl 4():S240-2. PubMed ID: 3469154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity of ofloxacin against methicillin-resistant Staphylococcus aureus.
    Mraović M; Canić-Radojlović M
    Infection; 1986; 14 Suppl 4():S231-2. PubMed ID: 3469151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of amifloxacin (WIN 49,375) compared with those of ciprofloxacin and ofloxacin.
    Digranes A
    Acta Pathol Microbiol Immunol Scand B; 1987 Feb; 95(1):29-32. PubMed ID: 3105246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro activity of tobramycin and gentamicin on three different media.
    Sandven P; Lassen J; Solberg O; Evandt O
    Chemotherapy; 1980; 26(5):354-60. PubMed ID: 7389429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vitro activity of gentamicin, tobramycin and netilmicin against 500 clinical isolates of bacteria. A comparative study using three different test media.
    Digranes A; Dibb WL; Benonisen E; Ostervold B
    Acta Pathol Microbiol Immunol Scand B; 1983 Apr; 91(2):135-9. PubMed ID: 6408889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gentamicin and tobramycin--an in vitro comparison using 1400 clinical isolates.
    Forgan-Smith WR; Andrew JH; McSweeney RJ
    Pathology; 1976 Jul; 8(3):195-9. PubMed ID: 826868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of PD 117596-2, a broad-spectrum difluoroquinolone.
    Neu HC; Chin NX
    Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):644-50. PubMed ID: 2506029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969).
    Espinoza AM; Chin NX; Novelli A; Neu HC
    Antimicrob Agents Chemother; 1988 May; 32(5):663-70. PubMed ID: 3293524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gentamicin and amikacin---an in vitro comparison using 1000 clinical isolates.
    Forgan-Smith WR; McSweeney RJ
    Aust N Z J Med; 1978 Aug; 8(4):383-6. PubMed ID: 282852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activity of RO 23-6240 (fleroxacin), a new 4-quinolone derivative.
    Machka K; Braveny I
    Eur J Clin Microbiol; 1987 Aug; 6(4):482-5. PubMed ID: 3117538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of the new 4-quinolone compound Ro 23-6240.
    Clarke AM; Zemcov SJ
    Eur J Clin Microbiol; 1987 Apr; 6(2):161-4. PubMed ID: 3109895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro studies with sisomicin and gentamicin.
    Shadomy S; Utz CJ; Shadomy HJ
    Chemotherapy; 1976; 22(6):346-52. PubMed ID: 821725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activity of three new quinolone antibiotics against recent clinical isolates.
    Forsgren A
    Scand J Infect Dis; 1985; 17(1):91-4. PubMed ID: 3158070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibacterial activity of sisomicin in comparison with gentamicin].
    Scheer M
    Arzneimittelforschung; 1976; 26(5):772-8. PubMed ID: 9099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-bacterial effect of ofloxacin--in vitro and in vivo results].
    Altay G; Tulunay C
    Mikrobiyol Bul; 1985 Oct; 19(4):183-9. PubMed ID: 3868736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.
    Cullmann W; Stieglitz M; Baars B; Opferkuch W
    Chemotherapy; 1985; 31(1):19-28. PubMed ID: 3156025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro activity of newer quinolones against aerobic bacteria.
    Auckenthaler R; Michéa-Hamzehpour M; Pechère JC
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of netilmicin (SCH 20569) against bacterial isolates from ill children.
    Greenstone G; Hammerberg S; Marks MI
    Chemotherapy; 1978; 24(1):29-33. PubMed ID: 412647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro antibacterial activity of levofloxacin against hospital isolates: a multicentre study.
    Soussy CJ; Cluzel M; Ploy MC; Kitzis MD; Morel C; Bryskier A; Courvalin P
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():43-50. PubMed ID: 10404337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.